Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
This study has been completed.
Study NCT00079820   Information provided by Sanofi-Aventis
First Received: March 15, 2004   Last Updated: January 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smallpox
Additional conditions recognized in this trial
Vaccinia
More general conditions related to this trial
DNA Virus Infections
Poxviridae Infections
Virus Diseases
Interventions listed in this trial
ACAM3000 MVA Vaccine
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services